Bain Capital, LP is one of the world’s leading private multi-asset alternative investment firms with approximately $95 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact ir@baincapital.com.

Sign on to your account

Harris Weber

Harris Weber

Associate
Life Sciences
Boston

Experience

Mr. Weber joined Bain Capital Life Sciences in 2017. He is an Associate.

Prior to joining Bain Capital Life Sciences, Mr. Weber worked at J.P. Morgan in their healthcare investment banking group, assisting both large and small pharma/biotech clients across several transaction teams, including buy-side and sell-side M&A, equity, and debt financings.  Prior to J.P Morgan, he spent time in a business development role at Vaccinex, a clinical stage biotechnology company engaged in antibody discovery in immuno-oncology and neurodegeneration. 


Education

Mr. Weber graduated summa cum laude from the University of Rochester as a member of the REMS program with a B.S. in Cell and Developmental Biology and a B.A. in Business.